Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.025 | 0.6 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.7 |
mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.14 | 0.7 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |